Neurotherapeutics [electronic resource] : Emerging Strategies /

Neuroscience's inherent complexity and rapid growth mean that no one can keep abreast of all the changes across the field. We each bring a necessarily narrow perspective. Neurotherapeutics: Emerg­ ing Strategies is an attempt to provide some diverse perspectives within the hunt for new drugs to treat central nervous system diseases. The book's premise is that the search for new drugs is based on an understanding ofboth clinical and basic sciences. Neurotherapeu­ tics: Emerging Strategies begins with psychiatry and concludes with neurological disorders. Each chapter examines a disease, including clinical features and existing treatments, but the emphasis is on current concepts of underlying causes and novel strategies for drug discovery arising from these possible mechanisms. Participating authors include basic neuroscientists, industry-based pharmacolo­ gists and chemists, and clinicians. The chapters describe the status of the existing disease treat­ ments, and when treatments are lacking, the approach is more basic science oriented. When there is a long history of treatment, there is greater emphasis on those therapies. However, all the chapters seem to reflect the benefits of cloning, since the availability of receptor subtypes now promises the opportunity for greater specificity of drug effects. Modulation of second messengers is another new and recur­ ring theme. And in the chapter on cachexia, cytokines are explored both as drugs and drug targets. Neurotherapeutics: Emerging Strategies reflects the complex­ ity of the nervous system, but the overriding message is hope for new and better drugs to treat those diseases that rob us of ourselves.

Saved in:
Bibliographic Details
Main Authors: Pullan, Linda M. editor., Patel, Jitendra. editor., SpringerLink (Online service)
Format: Texto biblioteca
Language:eng
Published: Totowa, NJ : Humana Press : Imprint: Humana Press, 1996
Subjects:Medicine., Pharmacology., Biomedicine., Pharmacology/Toxicology.,
Online Access:http://dx.doi.org/10.1007/978-1-59259-466-5
Tags: Add Tag
No Tags, Be the first to tag this record!
id KOHA-OAI-TEST:204367
record_format koha
institution COLPOS
collection Koha
country México
countrycode MX
component Bibliográfico
access En linea
En linea
databasecode cat-colpos
tag biblioteca
region America del Norte
libraryname Departamento de documentación y biblioteca de COLPOS
language eng
topic Medicine.
Pharmacology.
Biomedicine.
Pharmacology/Toxicology.
Medicine.
Pharmacology.
Biomedicine.
Pharmacology/Toxicology.
spellingShingle Medicine.
Pharmacology.
Biomedicine.
Pharmacology/Toxicology.
Medicine.
Pharmacology.
Biomedicine.
Pharmacology/Toxicology.
Pullan, Linda M. editor.
Patel, Jitendra. editor.
SpringerLink (Online service)
Neurotherapeutics [electronic resource] : Emerging Strategies /
description Neuroscience's inherent complexity and rapid growth mean that no one can keep abreast of all the changes across the field. We each bring a necessarily narrow perspective. Neurotherapeutics: Emerg­ ing Strategies is an attempt to provide some diverse perspectives within the hunt for new drugs to treat central nervous system diseases. The book's premise is that the search for new drugs is based on an understanding ofboth clinical and basic sciences. Neurotherapeu­ tics: Emerging Strategies begins with psychiatry and concludes with neurological disorders. Each chapter examines a disease, including clinical features and existing treatments, but the emphasis is on current concepts of underlying causes and novel strategies for drug discovery arising from these possible mechanisms. Participating authors include basic neuroscientists, industry-based pharmacolo­ gists and chemists, and clinicians. The chapters describe the status of the existing disease treat­ ments, and when treatments are lacking, the approach is more basic science oriented. When there is a long history of treatment, there is greater emphasis on those therapies. However, all the chapters seem to reflect the benefits of cloning, since the availability of receptor subtypes now promises the opportunity for greater specificity of drug effects. Modulation of second messengers is another new and recur­ ring theme. And in the chapter on cachexia, cytokines are explored both as drugs and drug targets. Neurotherapeutics: Emerging Strategies reflects the complex­ ity of the nervous system, but the overriding message is hope for new and better drugs to treat those diseases that rob us of ourselves.
format Texto
topic_facet Medicine.
Pharmacology.
Biomedicine.
Pharmacology/Toxicology.
author Pullan, Linda M. editor.
Patel, Jitendra. editor.
SpringerLink (Online service)
author_facet Pullan, Linda M. editor.
Patel, Jitendra. editor.
SpringerLink (Online service)
author_sort Pullan, Linda M. editor.
title Neurotherapeutics [electronic resource] : Emerging Strategies /
title_short Neurotherapeutics [electronic resource] : Emerging Strategies /
title_full Neurotherapeutics [electronic resource] : Emerging Strategies /
title_fullStr Neurotherapeutics [electronic resource] : Emerging Strategies /
title_full_unstemmed Neurotherapeutics [electronic resource] : Emerging Strategies /
title_sort neurotherapeutics [electronic resource] : emerging strategies /
publisher Totowa, NJ : Humana Press : Imprint: Humana Press,
publishDate 1996
url http://dx.doi.org/10.1007/978-1-59259-466-5
work_keys_str_mv AT pullanlindameditor neurotherapeuticselectronicresourceemergingstrategies
AT pateljitendraeditor neurotherapeuticselectronicresourceemergingstrategies
AT springerlinkonlineservice neurotherapeuticselectronicresourceemergingstrategies
_version_ 1756267965293002752
spelling KOHA-OAI-TEST:2043672018-07-30T23:32:56ZNeurotherapeutics [electronic resource] : Emerging Strategies / Pullan, Linda M. editor. Patel, Jitendra. editor. SpringerLink (Online service) textTotowa, NJ : Humana Press : Imprint: Humana Press,1996.engNeuroscience's inherent complexity and rapid growth mean that no one can keep abreast of all the changes across the field. We each bring a necessarily narrow perspective. Neurotherapeutics: Emerg­ ing Strategies is an attempt to provide some diverse perspectives within the hunt for new drugs to treat central nervous system diseases. The book's premise is that the search for new drugs is based on an understanding ofboth clinical and basic sciences. Neurotherapeu­ tics: Emerging Strategies begins with psychiatry and concludes with neurological disorders. Each chapter examines a disease, including clinical features and existing treatments, but the emphasis is on current concepts of underlying causes and novel strategies for drug discovery arising from these possible mechanisms. Participating authors include basic neuroscientists, industry-based pharmacolo­ gists and chemists, and clinicians. The chapters describe the status of the existing disease treat­ ments, and when treatments are lacking, the approach is more basic science oriented. When there is a long history of treatment, there is greater emphasis on those therapies. However, all the chapters seem to reflect the benefits of cloning, since the availability of receptor subtypes now promises the opportunity for greater specificity of drug effects. Modulation of second messengers is another new and recur­ ring theme. And in the chapter on cachexia, cytokines are explored both as drugs and drug targets. Neurotherapeutics: Emerging Strategies reflects the complex­ ity of the nervous system, but the overriding message is hope for new and better drugs to treat those diseases that rob us of ourselves.1 • Schizophrenia Treatment Strategies -- 2 • Affective Disorders -- 3 • Anxiety and Panic Disorders -- 4 • Acute and Chronic Disease: Neurological Manifestations -- 5 • Opioids and the Control of Pain -- 6 • Epilepsy -- 7 • Neuroprotective Strategies for Treatment of Acute Ischemic Stroke -- 8 • Huntington’s Disease -- 9 • Parkinson’s Disease -- 10 • Alzheimer’s Disease.Neuroscience's inherent complexity and rapid growth mean that no one can keep abreast of all the changes across the field. We each bring a necessarily narrow perspective. Neurotherapeutics: Emerg­ ing Strategies is an attempt to provide some diverse perspectives within the hunt for new drugs to treat central nervous system diseases. The book's premise is that the search for new drugs is based on an understanding ofboth clinical and basic sciences. Neurotherapeu­ tics: Emerging Strategies begins with psychiatry and concludes with neurological disorders. Each chapter examines a disease, including clinical features and existing treatments, but the emphasis is on current concepts of underlying causes and novel strategies for drug discovery arising from these possible mechanisms. Participating authors include basic neuroscientists, industry-based pharmacolo­ gists and chemists, and clinicians. The chapters describe the status of the existing disease treat­ ments, and when treatments are lacking, the approach is more basic science oriented. When there is a long history of treatment, there is greater emphasis on those therapies. However, all the chapters seem to reflect the benefits of cloning, since the availability of receptor subtypes now promises the opportunity for greater specificity of drug effects. Modulation of second messengers is another new and recur­ ring theme. And in the chapter on cachexia, cytokines are explored both as drugs and drug targets. Neurotherapeutics: Emerging Strategies reflects the complex­ ity of the nervous system, but the overriding message is hope for new and better drugs to treat those diseases that rob us of ourselves.Medicine.Pharmacology.Biomedicine.Pharmacology/Toxicology.Springer eBookshttp://dx.doi.org/10.1007/978-1-59259-466-5URN:ISBN:9781592594665